Evidence map›Paper›PMID 42835046›Full record

ArticleFrontiers in oncology2026

Explainable AI-based prognostication of patients with resectable colorectal liver metastases using preoperative clinical parameters: is it comparable to traditional clinical scoring systems?

Nikhil Pramod Kumar, Sarkis Drejian, Mehdi Sadat Akhavi, Hemin Ali Qadir, Åsmund Avdem Fretland, Airazat M Kazaryan, Davit Aghayan, Ilangko Balasingham, Bjørn Edwin

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nikhil Pramod Kumar *The Intervention Centre, Oslo University Hospital, Oslo, Norway.
Sarkis Drejian *The Intervention Centre, Oslo University Hospital, Oslo, Norway.
Mehdi Sadat AkhaviThe Intervention Centre, Oslo University Hospital, Oslo, Norway.
Hemin Ali QadirThe Intervention Centre, Oslo University Hospital, Oslo, Norway.
Åsmund Avdem FretlandThe Intervention Centre, Oslo University Hospital, Oslo, Norway.
Airazat M KazaryanThe Intervention Centre, Oslo University Hospital, Oslo, Norway.
Davit AghayanThe Intervention Centre, Oslo University Hospital, Oslo, Norway.
Ilangko BalasinghamThe Intervention Centre, Oslo University Hospital, Oslo, Norway.
Bjørn EdwinThe Intervention Centre, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prognostication for patients undergoing liver resection for colorectal liver metastases (CRLM) remains challenging. Artificial intelligence-based survival models may improve individualized risk estimation. Methods: We developed and compared classical machine learning and deep learning survival models using exclusively preoperative clinical variables from 350 patients undergoing first-time liver resection for CRLM. Models included Cox proportional hazards (CoxPH), random survival forest (RSF), support vector machine for survival (SVM), XGBoost survival, DeepSurv, and DeepHit. Model performance was evaluated using the concordance index (C-index) and the Integrated Brier Score (IBS) on a training set of 245 patients, testing set of 105 patients, and an independent internal validation set of 88 patients from the OSLO-COMET trial. Model interpretability was assessed using SHapley Additive explanation (SHAP) analysis. The results of the developed models were compared to well established Basingstoke Predictive Index (BPI). Results: On internal validation cohort, CoxPH demonstrated the most consistent performance on the internal validation set (C-index 0.59), and on the test set patients (C-index 0.65), comparable to more complex machine learning and deep learning models. Although RSF achieved the highest training performance, this did not translate into superior performance both on the test and the internal validation datasets. CoxPH and DeepSurv models showed comparable 1-, 3-, and 5-year individual prediction to BPI. SHAP analysis consistently identified ASA score, lobar distribution, primary tumor location and number of metastases as the most influential predictors across models. Conclusions: Using structured preoperative clinical data, we developed machine-and deep-learning models to predict overall survival in patients with CRLM. Given that the models were based exclusively on preoperative clinical variables, their performance is encouraging. Predictive accuracy may be further improved by incorporating additional data modalities, particularly radiological features as well as by training on larger datasets.

Indexed as

colorectal liver metastasesdeep learningmachine learningmodel interpretabilitysurvival prediction

Identifiers

PMID42835046
PMCPMC13634838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.